MAPK3 and colorectal carcinoma: Our data are in line with a previous study showing that inhibiting ERK1/2 activity by U0126 significantly suppresses the transcription activity of MMP-2 by inhibiting the phosphorylation of hnRNPK and its nuclear translocation in colorectal cancer (CRC) cells [46].